Atlantic Equities Upgrades Bristol-Myers Squibb Co. (BMY) to Neutral
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $67.01 +2.35%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Atlantic Equities upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Underweight to Neutral following FDA approval of ELIQUIS.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $31.90 yesterday.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $31.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
- Bloom Burton & Co. Upgrades Aurinia Pharmaceuticals (AUPH) to Buy (1)
- JPMorgan Upgrades TIC Solutions (TIC) to Neutral
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
